Revista Española de Cardiología (English Edition) Revista Española de Cardiología (English Edition)
Rev Esp Cardiol. 2018;71:996-8 - Vol. 71 Num.12 DOI: 10.1016/j.rec.2018.06.032

PCSK9 Inhibitors: From Innovation to Sustainable Clinical Application

Iñaki Lekuona a,

a Servicio Cardiología, Hospital Galdakao-Usansolo OSI Barrualde, Galdácano, Vizcaya, Spain

Refers to

Number of Patients Eligible for PCSK9 Inhibitors Based on Real-world Data From 2.5 Million Patients
Alberto Zamora, Luís Masana, Marc Comas-Cufi, Núria Plana, Àlex Vila, Maria García-Gil, Lia Alves-Cabratosa, Roberto Elosua, Jaume Marrugat, Rafel Ramos
Rev Esp Cardiol. 2018;71:1010-7
Abstract - Full text - PDF

Article

You can access the full text of this article:

Members of the Spanish Society of Cardiology


Subscribers of Revista Española de Cardiología

You may purchase this article for 30.00 €

Buy Now
Subscribers of ScienceDirect

1885-5857/© 2018 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved

Cookies
x
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.
Cookies policy
x
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.